128 related articles for article (PubMed ID: 11248852)
1. [Development of a novel influenza vaccine derived from a continuous cell line].
Kistner O; Barrett N; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
ALTEX; 2001; 18(1):50-4. PubMed ID: 11248852
[TBL] [Abstract][Full Text] [Related]
2. A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
Wien Klin Wochenschr; 1999 Mar; 111(5):207-14. PubMed ID: 10226351
[TBL] [Abstract][Full Text] [Related]
3. Development of a Vero cell-derived influenza whole virus vaccine.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
[TBL] [Abstract][Full Text] [Related]
4. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
5. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
6. Production of influenza virus in serum-free mammalian cell cultures.
Merten OW; Manuguerra JC; Hannoun C; van der Werf S
Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
[TBL] [Abstract][Full Text] [Related]
7. Continuous cell lines as a production system for influenza vaccines.
Genzel Y; Reichl U
Expert Rev Vaccines; 2009 Dec; 8(12):1681-92. PubMed ID: 19943763
[TBL] [Abstract][Full Text] [Related]
8. Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine.
Chan CY; Tambyah PA
Expert Rev Vaccines; 2012 Jul; 11(7):759-73. PubMed ID: 22913252
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
10. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
11. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Dorner F
Vaccine; 1998; 16(9-10):960-8. PubMed ID: 9682344
[TBL] [Abstract][Full Text] [Related]
12. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
14. Statistical optimization of influenza H1N1 production from batch cultures of suspension Vero cells (sVero).
Paillet C; Forno G; Soldano N; Kratje R; Etcheverrigaray M
Vaccine; 2011 Sep; 29(41):7212-7. PubMed ID: 21756959
[TBL] [Abstract][Full Text] [Related]
15. Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.
Montomoli E; Khadang B; Piccirella S; Trombetta C; Mennitto E; Manini I; Stanzani V; Lapini G
Expert Rev Vaccines; 2012 May; 11(5):587-94. PubMed ID: 22827244
[TBL] [Abstract][Full Text] [Related]
16. Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production.
Coussens PM; Smith KA; Weber PS; Colvin CJ
Vaccine; 2011 Nov; 29(47):8661-8. PubMed ID: 21911025
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.
Szymczakiewicz-Multanowska A; Groth N; Bugarini R; Lattanzi M; Casula D; Hilbert A; Tsai T; Podda A
J Infect Dis; 2009 Sep; 200(6):841-8. PubMed ID: 19673651
[TBL] [Abstract][Full Text] [Related]
18. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines.
Kalbfuss B; Genzel Y; Wolff M; Zimmermann A; Morenweiser R; Reichl U
Biotechnol Bioeng; 2007 May; 97(1):73-85. PubMed ID: 16921531
[TBL] [Abstract][Full Text] [Related]
19. Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
Brands R; Visser J; Medema J; Palache AM; van Scharrenburg GJ
Dev Biol Stand; 1999; 98():93-100; discussion 111. PubMed ID: 10494962
[TBL] [Abstract][Full Text] [Related]
20. A cell-based backup to speed up pandemic influenza vaccine production.
Lee MS; Hu AY
Trends Microbiol; 2012 Mar; 20(3):103-5. PubMed ID: 22257962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
